Heneine W, Switzer W M, Soucie J M, Evatt B L, Shanmugam V, Rosales G V, Matthews A, Sandstrom P, Folks T M
HIV and Retrovirology Branch, Centers for Disease Control and Prevention, 1600 Clifton Road, Atlanta, GA 30333, USA.
J Infect Dis. 2001 Feb 15;183(4):648-52. doi: 10.1086/318540. Epub 2001 Jan 12.
Since 1984, unheated porcine clotting factor VIII (Hyate:C) has been used to treat severe bleeding episodes in persons with hemophilia who have antibodies to human clotting factor. We document the presence of porcine endogenous retrovirus (PERV) in plasma samples of pigs and in clinical lots of Hyate:C. Both gag and pol PERV RNA sequences were detected by reverse-transcriptase (RT) polymerase chain reaction in 13 of 13 lots of Hyate:C tested. Among 10 of these lots, RT activity also was detected, which confirms the presence of retroviral particles. To assess the transmission of PERV to Hyate:C recipients, we tested serum specimens from 88 recipients of Hyate:C and 23 noninfused control subjects for anti-PERV antibodies by using a Western blot assay. None of the samples was positive. Our data document that PERV particles are a common contaminant of Hyate:C products and suggest that the risk of PERV transmission from these percutaneous exposures is very low.
